Showing results (261-270 of 326) with videos related to
Sort By:
Pageof 33
Antiviral Research|January 25, 2024
A lipid index for risk of hyperlipidemia caused by anti-retroviral drugsMari Shimura, Nobuyo Higashi-Kuwata, Asuka Fujiwara, et al.International Journal of Oncology|December 23, 2014
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cellsNaoko Wada, Yawara Kawano, Shiho Fujiwara, et al.RSC Advances|June 2, 2023
Synthesis of novel entecavir analogues having 4'-cyano-6''-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agentHiroki Kumamoto, Nobuyo Higashi-Kuwata, Sanae Hayashi, et al.Cancer Science|August 2, 2019
Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cellsNao Nishimura, Mohamed O Radwan, Masayuki Amano, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2021
Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching StudyShohei Yamamoto, Kenji Maeda, Kouki Matsuda, et al.Proceedings of the National Academy of Sciences of the United States of America|September 5, 2024
Structural and virologic mechanism of the emergence of resistance to Mpro inhibitors in SARS-CoV-2Shin-Ichiro Hattori, Haydar Bulut, Hironori Hayashi, et al.Bioorganic & Medicinal Chemistry Letters|January 25, 2011
Spirodiketopiperazine-based CCR5 antagonist: discovery of an antiretroviral drug candidateRena Nishizawa, Toshihiko Nishiyama, Katsuya Hisaichi, et al.Blood|March 1, 2003
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biologyRichard F Little, Stefania Pittaluga, Nicole Grant, et al.Journal of Medicinal Chemistry|August 26, 2015
Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray StudiesArun K Ghosh, Cuthbert D Martyr, Heather L Osswald, et al.Scientific Reports|September 14, 2022
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal studyJunko S Takeuchi, Ami Fukunaga, Shohei Yamamoto, et al.Pageof 33